Table 2. Baseline characteristics of the nineteen participants that completed the study.
| Variable | Median (25th-75th) | Range |
|---|---|---|
| Age (years) | 56 (47.5–57.0) | (38–59) |
| Height (cm) | 172.0 (168.3–176.2) | (154.0–192.0) |
| Weight (kg) | 89 (81.55–104.99) | (67.60–128.40) |
| Body mass index (kg/m²) | 30.44 (27.15–36.37) | (23.10–41.00) |
| Body fat percentage | 34.50 (23.60–36.45) | (15.60–46.60) |
| Waist circumference (cm) | 106.5 (100.5–117.25) | (85.0–132.0) |
| Months of diabetes duration | 49 (30.5–87) | (6–300) |
| Fasting venous glucose (mg/dL) | 124.0 (110.5–138.5) | (81–191) |
| Fasting insulin (μUI/mL) | 12.80 (11.50–19.00) | (4.00–33.68) |
| HbA1c percentage | 7.0 (6.3–7.6) | (5.6–8.3) |
| HOMA-IR | 4.20 (3.00–6.67) | (1.20–9.70) |
| HOMA-β | 89.40 (55.65–130.05) | (23.70–676.64) |
HbA1c: Glycated hemoglobin; HOMA-IR: Homeostasis model assessment of insulin resistance; HOMA-β: Homeostasis model assessment of beta-cell function.